why choose us

First received: September 27, 2023

Clinical Trial: A Study to Test the Effect of BI 456906 on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesi

Brief Summary: This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more.People can take part if they have cardiovascular or chronic kidney disease.People who have at least 2 health problems related to their weight or risks of cardiovascular disease can participate.Participants must have previously tried to lose weight by changing their diet.The purpose of this study is to find out whether people with overweight or obesity who take a medicine called BI 456906…

Read more